These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32888121)

  • 1. Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial.
    Zhao Y; Krupadev V; Dagher L; Mahnkopf C; Sohns C; Sehner S; Suling A; Sanders P; Boersma L; Schunkert H; Wegscheider K; Brachmann J; Marrouche NF
    J Interv Card Electrophysiol; 2021 Sep; 61(3):609-615. PubMed ID: 32888121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhythm control versus rate control for atrial fibrillation and heart failure.
    Roy D; Talajic M; Nattel S; Wyse DG; Dorian P; Lee KL; Bourassa MG; Arnold JM; Buxton AE; Camm AJ; Connolly SJ; Dubuc M; Ducharme A; Guerra PG; Hohnloser SH; Lambert J; Le Heuzey JY; O'Hara G; Pedersen OD; Rouleau JL; Singh BN; Stevenson LW; Stevenson WG; Thibault B; Waldo AL;
    N Engl J Med; 2008 Jun; 358(25):2667-77. PubMed ID: 18565859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data.
    Chen S; Pürerfellner H; Meyer C; Acou WJ; Schratter A; Ling Z; Liu S; Yin Y; Martinek M; Kiuchi MG; Schmidt B; Chun KRJ
    Eur Heart J; 2020 Aug; 41(30):2863-2873. PubMed ID: 31298266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter Ablation for Atrial Fibrillation with Heart Failure.
    Marrouche NF; Brachmann J; Andresen D; Siebels J; Boersma L; Jordaens L; Merkely B; Pokushalov E; Sanders P; Proff J; Schunkert H; Christ H; Vogt J; Bänsch D;
    N Engl J Med; 2018 Feb; 378(5):417-427. PubMed ID: 29385358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Zafeiropoulos S; Doundoulakis I; Bekiaridou A; Farmakis IT; Papadopoulos GE; Coleman KM; Giannakoulas G; Zanos S; Tsiachris D; Duru F; Saguner AM; Mountantonakis SE; Stavrakis S
    JACC Clin Electrophysiol; 2024 Jul; 10(7 Pt 1):1395-1405. PubMed ID: 38727662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.
    Hudoyo AW; Fukuda H; Imazu M; Shindo K; Fu H; Iwata Y; Ito S; Kitakaze M
    Hypertens Res; 2019 Nov; 42(11):1716-1725. PubMed ID: 31209398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Yamamoto M; Hamada-Harimura Y; Machino T; Yamasaki H; Sekiguchi Y; Nogami A; Aonuma K; Ieda M
    J Cardiol; 2019 Sep; 74(3):235-244. PubMed ID: 30910388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
    Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
    Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of β-blockers on 1-year survival and hospitalizations in patients with heart failure and atrial fibrillation: results from ESC-HF Pilot and ESC-HF Long-Term Registry.
    Ozierański K; Kapłon-Cieślicka A; Balsam P; Tymińska A; Wancerz A; Peller M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Pol Arch Intern Med; 2018 Nov; 128(11):649-657. PubMed ID: 30303491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
    Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
    Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A
    Card Electrophysiol Rev; 2003 Jun; 7(2):178-84. PubMed ID: 14618047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial.
    Brachmann J; Sohns C; Andresen D; Siebels J; Sehner S; Boersma L; Merkely B; Pokushalov E; Sanders P; Schunkert H; Bänsch D; Dagher L; Zhao Y; Mahnkopf C; Wegscheider K; Marrouche NF
    JACC Clin Electrophysiol; 2021 May; 7(5):594-603. PubMed ID: 33640355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-Analysis.
    Depoorter L; Sels L; Deschodt M; Van Grootven B; Van der Linden L; Tournoy J
    Drugs Aging; 2020 Jan; 37(1):19-26. PubMed ID: 31745834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
    Ogawa S; Yamashita T; Yamazaki T; Aizawa Y; Atarashi H; Inoue H; Ohe T; Ohtsu H; Okumura K; Katoh T; Kamakura S; Kumagai K; Kurachi Y; Kodama I; Koretsune Y; Saikawa T; Sakurai M; Sugi K; Tabuchi T; Nakaya H; Nakayama T; Hirai M; Fukatani M; Mitamura H;
    Circ J; 2009 Feb; 73(2):242-8. PubMed ID: 19060419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial.
    Slee A; Saksena S
    Am Heart J; 2020 Feb; 220():1-11. PubMed ID: 31756389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm control of atrial fibrillation in heart failure.
    Heijman J; Voigt N; Abu-Taha IH; Dobrev D
    Heart Fail Clin; 2013 Oct; 9(4):407-15, vii-viii. PubMed ID: 24054474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.